Please use this identifier to cite or link to this item: https://doi.org/10.18632/oncotarget.4301
DC FieldValue
dc.titleDose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients
dc.contributor.authorZhang, L
dc.contributor.authorYang, Z.-Z
dc.contributor.authorChen, X.-X
dc.contributor.authorTuan, J
dc.contributor.authorMa, J.-L
dc.contributor.authorMei, X
dc.contributor.authorYu, X.-L
dc.contributor.authorZhou, Z.-R
dc.contributor.authorShao, Z.-M
dc.contributor.authorLiu, G.-Y
dc.contributor.authorGuo, X.-M
dc.date.accessioned2020-10-27T05:48:59Z
dc.date.available2020-10-27T05:48:59Z
dc.date.issued2015
dc.identifier.citationZhang, L, Yang, Z.-Z, Chen, X.-X, Tuan, J, Ma, J.-L, Mei, X, Yu, X.-L, Zhou, Z.-R, Shao, Z.-M, Liu, G.-Y, Guo, X.-M (2015). Dose coverage of axillary level I-III areas during whole breast irradiation with simplified intensity modulated radiation therapy in early stage breast cancer patients. Oncotarget 6 (20) : 18183-18191. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.4301
dc.identifier.issn19492553
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/180945
dc.description.abstractPurpose: This study was designed to evaluate the dose coverage of axillary areas during whole breast irradiation with simplified intensity modulated radiation therapy (s-IMRT) and field-in-field IMRT (for-IMRT) in early stage breast cancer patients. Methods: Sixty-one consecutive patients with breast-conserving surgery and sentinel lymph node biopsy were collected. Two plans were created for each patient: the s-IMRT and for-IMRT plan. Dosimetric parameters of axillary areas were compared. Results: The average of mean doses delivered to the axillary level I areas in s-IMRT and for-IMRT plan were 27.7Gy and 29.1Gy (p = 0.011), respectively. The average of V47.5Gy, V45Gy and V40Gy (percent volume receiving? 47.5Gy, 45Gy and 40Gy) of the axillary level I in s-IMRT plan was significantly lower than that in for-IMRT plan (p < 0.001). For for-IMRT plans, patients with upper tangential border to humeral head ?2cm, breast separation >19.3cm and body width >31.9cm had significantly higher mean dose in axillary level I area (p = 0.002, 0.007, 0.001, respectively). Conclusion: Compared with for-IMRT plan, the s-IMRT plan delivered lower dose to axillary level I area. For centers using s-IMRT technique, caution should be exercised when selecting to omit axillary lymph node dissection for patients with breast conserving surgery and limited positive SLNs.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectadult
dc.subjectaged
dc.subjectArticle
dc.subjectbreast cancer
dc.subjectcancer staging
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectdosimetry
dc.subjectfemale
dc.subjectfield in field intensity modulated radiation therapy
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectintensity modulated radiation therapy
dc.subjectmajor clinical study
dc.subjectpartial mastectomy
dc.subjectradiation dose distribution
dc.subjectsentinel lymph node biopsy
dc.subjectsimplified intensity modulated radiation therapy
dc.subjecttumor biopsy
dc.subjectadjuvant radiotherapy
dc.subjectadverse effects
dc.subjectBreast Neoplasms
dc.subjectlymph node dissection
dc.subjectlymph node metastasis
dc.subjectmastectomy
dc.subjectmiddle aged
dc.subjectpathology
dc.subjectprocedures
dc.subjectradiation dose
dc.subjecttreatment outcome
dc.subjectx-ray computed tomography
dc.subjectAdult
dc.subjectAged
dc.subjectBreast Neoplasms
dc.subjectFemale
dc.subjectHumans
dc.subjectLymph Node Excision
dc.subjectLymphatic Metastasis
dc.subjectMastectomy
dc.subjectMiddle Aged
dc.subjectNeoplasm Staging
dc.subjectRadiation Dosage
dc.subjectRadiotherapy, Adjuvant
dc.subjectRadiotherapy, Intensity-Modulated
dc.subjectSentinel Lymph Node Biopsy
dc.subjectTomography, X-Ray Computed
dc.subjectTreatment Outcome
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.18632/oncotarget.4301
dc.description.sourcetitleOncotarget
dc.description.volume6
dc.description.issue20
dc.description.page18183-18191
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_18632_oncotarget_4301.pdf1.35 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons